Proteomic analysis of differentially expressed proteins in vitamin C-treated AGS cells by unknown
Nagappan et al. BMC Biochemistry 2013, 14:24
http://www.biomedcentral.com/1471-2091/14/24RESEARCH ARTICLE Open AccessProteomic analysis of differentially expressed
proteins in vitamin C-treated AGS cells
Arulkumar Nagappan1†, Hyeon Soo Park1†, Kwang Il Park2, Jin A Kim3, Gyeong Eun Hong1, Sang Rim Kang4,
Jue Zhang5, Eun Hee Kim6, Won Sup Lee7, Chung Kil Won1 and Gon Sup Kim1*Abstract
Background: Vitamin C (ascorbic acid) is an essential nutrient of most living tissues that readily acts as a strong
reducing agent, which is abundant in fruits and vegetables. Although, it inhibits cell growth in many human cancer
cells in vitro, treatment in cancer is still controversial. Hence, the purpose of this study was to investigate the
molecular mechanism of the inhibitory effect of vitamin C on AGS cell growth, and protein profiles in AGS cells
after exposure to vitamin C treatment, by using proteomic tools.
Results: Vitamin C showed a cytotoxic effect on AGS cells (IC50 300 μg/mL) and, 20 differentially expressed
proteins (spot intensities which show ≥2 fold change and statistically significant, p<0.05 between the control and
vitamin-C treated group) were successfully identified by assisted laser desorption/ ionization-time of flight/mass
spectrometry (MALDI-TOF/MS). Of the 20 proteins, six were up-regulated and fourteen were down-regulated.
Specifically, 14-3-3σ, 14-3-3ε, 14-3-3δ, tropomyosin alpha-3 chain and tropomyosin alpha-4 chain were down-
regulated and peroxiredoxin-4 and thioredoxin domain-containing proteins 5 were up-regulated. The identified
proteins are mainly involved in cell mobility, antioxidant and detoxification, signal transduction and protein
metabolism. Further, the expressions of 14-3-3 isoforms were verified with immuno-blotting analysis.
Conclusions: Our proteome results suggest that the apoptosis related proteins were involved in promoting and
regulating cell death of AGS cells, and might be helpful to understand the molecular mechanism of vitamin C on
AGS cell growth inhibition.
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Globally, gastric cancer is the second leading cause of
cancer-related death, and is the most prevalent cancer in
South Korea. In the past two decades, the mortality and in-
cidence of gastric cancer has decreased gradually but it is
still the second most common cancer in Asia [1]. Most
stomach cancers are an adenocarcinoma type, which ac-
counts approximately 90% [2]. The well-established risk
factors are Helicobacter pylori-infection and cigarette
smoking, and the role of dietary factors has also been sug-
gested [3]. The most widely used treatments for stomach
cancer are surgery, chemotherapy, and/or radiation therapy.* Correspondence: gonskim@gnu.ac.kr
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distribution, and reproduction in any mediumThe available treatments are not effective and recuperation
is also still problematic. Hence, there is an urgency to apply
new therapeutic agents to increase survival rates of gastric
cancer patients.
Vitamin C (ascorbic acid) is an essential nutrient of
most living tissues, and readily acts as a strong reducing
agent [4]. Epidemiological studies have reported that vita-
min C deficiency in humans are linked to more severe H.
pylori-associated gastritis and a gastric cancer risk is also
higher [5]. The study reported that supplementation of
vitamin C has been associated with reduced gastric cancer
risk in humans. In addition, a reduced risk for most types
of cancer is associated with a high intake of fresh fruits
and vegetables, which contain vitamin C [6]. Despite, the
controversial cancer treatment history, the in-vitro studies
reported that ascorbate induces cell cycle arrest and apop-
tosis in various tumor cells [7,8]. However, the exacttral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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not fully elucidated.
A global proteomic approach is being extensively applied
in cancer research [9]. This approach uses a combination
of two-dimensional gel electrophoresis (2-DE), image ana-
lysis, matrix-assisted laser desorption/ ionization-time of
flight (MALDI-TOF) mass spectrometry (MS), and bio-
informatics analyses to comprehensively resolve, identify,
and characterize proteins in the cells, tissues and animal
models. These high-throughput proteome techniques allow
us to examine the changes in protein expression of AGS
cells in response to vitamin C. Identification of differen-
tially expressed proteins is important to understand the
molecular events involved in vitamin C anti-cancer mech-
anism and protective effects, as well as brings new insights
into AGS carcinogenesis. Regarding gastric cancer, prote-
ome analysis has been reported mainly in KATO-III and
EPG 85–257 human gastric cancer cell lines [10,11]. 2-DE
maps have also permitted to obtain an overview of the
expressed proteins in the human stomach [12]. Also, prote-
ome analysis has been carried out in 11 human gastric can-
cer samples to find the biomarkers of gastric cancer [13].
However, no 2-DE proteome of vitamin C-treated AGS
cells have hitherto been reported.
Our previous study demonstrated that vitamin C in-
duced apoptosis in human adenocarcinoma AGS cells at
pharmacological concentrations, and inhibited AGS cells
proliferation [14]. In the present study, we perform a
proteome analysis of AGS cells treated with vitamin C at
pharmacological concentrations (300μg) and the control
(only vehicle), and 20 different expressed proteins were
identified by MALDI-TOF/MS. Also, the expression of
isoforms of 14-3-3 proteins was confirmed by immuno-
blotting. The cytotoxicity assay suggests that vitamin C
inhibited AGS cells growth and proteome results re-
vealed that apoptosis related proteins were involved in
promoting and regulating cell death of AGS cells.
Methods
Chemical and reagents
RPMI 1640 medium was purchased from Hyclone (Logan,
UT, USA). Fetal bovine serum (FBS) and antibiotics
(streptomycin/penicillin) were purchased from Gibco (BRL
Life Technologies, Grand Island, NY, USA). Materials and
chemicals used for electrophoresis were obtained from
BioRad (Hercules, CA, USA). Antibody to 14-3-3σ and β-
actin were purchased from Millipore (Billerica, MA, USA).
14-3-3ε and 14-3-3δ were obtained from Bioworld Tech-
nology Inc. (St. Louis Park, MN, USA)). Vitamin C was
provided by Animal Resources Research Bank (ABRB). All
other chemicals used in this study were purchased from
AMRESCO (Solon, OH, USA) and Sigma-Aldrich (St.
Louis, MO, USA). All the chemicals used were of the
highest grade commercially available.Cell culture and treatments
AGS human gastric cancer cell line was purchased from
ATCC (Manassas, VA, USA). Cells were grown in RPMI
1640 medium supplemented with 10% FBS and 1% peni-
cillin/streptomycin (P-S), and grown in a humidified in-
cubator with 5% CO2 in air at 37°C. Experiments were
performed when cell growth was approximately 80%
confluent.
Cytotoxicity assay
The 3-(4, 5-dimethythiazol-2-yl)-2, 5-diphenyltetrazolium
bromide (MTT)-based assay was performed to determine
the cytotoxicity of vitamin C on AGS cells. Cells were
seeded at 10 × 104 cells/mL in a 12-well plate and incu-
bated for 24 h. Cells were treated with various concentra-
tions of vitamin C (100, 200, 300, 400, and 500 μg/mL) or
only vehicle (1X PBS used as the control) and incubated
for 24 h. After incubation, 100 μl of a MTT solution (5
mg/mL in 1X phosphate buffered saline, PBS) was added
to the wells and incubated for 3 h. Then, 500 μl of di-
methyl sulfoxide (DMSO) was added to each well after the
medium was removed completely to dissolve the cellular
crystalline deposits. The optical density was measured at
540 nm using an ELISA plate reader.
Protein extraction and two-dimensional gel
electrophoresis
A total of 1×107 cells was plated onto 100mL plates and
incubated overnight at 37°C in an atmosphere of 5% CO2.
Cells were treated with 300 μg/mL of vitamin C and 1X
PBS used as the control. After 24 h incubation, cells were
trypsinized and washed twice with cold 1X PBS. Then,
cells were lysed in a lysis buffer (7 M urea, 2 M thiourea,
and 4% (w/v) CHAPS) on ice for 1 h. The lysates were
centrifuged at 14000 rpm for 15 min at 4°C, and the col-
lected supernatant was stored at −80°C until analysis. Pro-
teins in lysates were precipitated with equal volume (1:1)
of 20% v/v trichloroacetic acid and dissolved in 7 M urea,
2 M thiourea, and 4% (w/v) CHAPS, 0.5% (v/v) IPG buffer,
and 1% dithiothreitol (DTT). Protein concentration was
determined by the Non-Interfering™ protein assay kit (G-
Biosciences, St. Louis, MO, USA), in accordance to the
manufacturer’s protocol. Immobilized 18 cm linear pH
gradient (IPG) strips, pH 4–7, were rehydrated in a rehy-
dration buffer (7 M urea, 2 M thiourea, 4% (w/v) CHAPS,
0.002% Bromophenol blue). For the first dimension, 100 μg
protein was focused using the Ettan IPG Phor II (GE
Healthcare) at 50 V for 1 h, followed by 200 V for 1 h,
500 V for 30 min, 4000 V for 30 min, 4000 V for 1 h,
10000 V for 1 h, 10000 V for 13 h, and 50 V for 3 h. The
focused strips were equilibrated twice, 15 min each time,
first with 10 mg/mL DTT and then with 40 mg/mL
iodoacetamide (IAA) prepared in equilibration buffer
containing 50 mM Tris–HCl (pH 8.8), 6 M urea, 30% (v/v)
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blue. The focused proteins were then separated in the sec-
ond dimension by 12% linear gradient SDS-PAGE with a
constant current of 20 mA/gel at 20°C. Gels were run until
the Bromophenol dye front reached the end of the gel.
Protein detection, analysis, and in-gel digestion
The gels were stained with silver nitrate, similar to the
method described by Swain and Ross [15] with slight mod-
ifications. Three independent gels were performed in tripli-
cate. Gels were scanned and image analysis was performed,
using Progenesis Samespots software (Nonlinear Dynam-
ics, Newcastle, UK). Using this software, the differentially
expressed spots were identified by automatic matching of
the detected protein spots. Those spots differing signifi-
cantly (p<0.05) in their intensities with a fold-change ≥2
were used for further analysis. Selected protein spots were
excised manually from the two-dimensional electrophor-
esis (2-DE) gel and protein digestion was performed [16]
with slight modifications. Briefly, the excised gel pieces
were washed with 100 μl of 100 mM NH4HCO3 for 5 min,
and then dehydrated in 100 μl of acetonitrile for 10 min.
After being dried in a lyophilizer (SFDSM06, Samwon
Freezing Engineering Co., Busan), the gel pieces were
rehydrated in 5–10 μl of 50 mM NH4HCO3 containing
20 ng/μl trypsin (Promega, Madison, WI, USA) on ice.
After 45 min, the trypsin solution was removed and re-
placed with 10–20 μl of 50 mM NH4HCO3 without trypsin,
and digestion was carried out for a minimum of 16 h at
37°C. These peptide mixtures were collected and analyzed
by a mass spectrometry.
Matrix-assisted laser desorption/ionization-time of flight
mass spectrometry (MALDI-TOF MS) mass spectrometry
and database searching
Tryptic peptides obtained as described above were subse-
quently extracted by an addition of 10 μl of the extraction
buffer, followed by an addition of 10–15 μl of acetonitrile.
Pooled extracts were dried in a lyophilizer (SFDSM06,
Samwon Freezing Engineering Co., Busan) and the extracts
were re-dissolved in 1 μl of extraction buffer and 1 μl
of matrix solution (α-acyano- 4-hydroxycinnamic acid,
HCCA) and targeted onto a MALDI-TOF plate. After
drying the samples completely onto the targeting plate,
MALDI-TOF/MS was conducted using a Voyager- DE
STR mass spectrometer (Applied Biosystems, Franklin
Lakes, NJ, USA) equipped with delay ion extraction. Mass
spectra were obtained over a mass range of 800–3,000 Da.
For identification of proteins, the peptide mass fingerprint-
ing data were used to search against the Swissprot database
using the Mascot program (http://www.matrixscience.com).
The following parameters were used for database searches:
taxonomy, Homo sapiens (human); cleavage specificity,
trypsin with one missed cleavage allowed; peptide toleranceof 100 ppm for the fragment ions; and allowed modifica-
tions, Cys Carbamidomethyl (fixed), and oxidation of Met
(variable). Protein scores >56 were considered statistically
significant (p<0.05).
Western blot analysis
AGS cells were cultured in 6-well plates and incubated
with vitamin C at 300 μg/mL or PBS as the solvent control
for 24 h. After incubation, cells were washed with ice-cold
PBS and lysed with a lysis buffer [50 mM Tris–HCl (pH
8.0), 150 mM NaCl, 0.5% sodium deoxycholate, 0.1% so-
dium dodecyl sulfate (SDS) and 1% NP-40], containing the
protease inhibitor cocktail. The cell debris was removed by
centrifugation at 13,000 rpm for 30 min and protein con-
centration was determined using a Bradford assay (Bio-
Rad). Proteins were separated by 10% SDS-polyacrylamide
gel electrophoresis (SDS-PAGE) and transferred to a
polyvinyldene fluoride (PVDF) membrane (Immunobilon-
P, 0.45 mm; Millipore) using the TE 77 Semi-Dry Transfer
Unit (CE Healthcare Life Sciences, Buckinghamshire, UK).
The membrane was blocked with 5% non-fat skim milk in
Tris-buffered saline containing 1% Tween-20 (TBS, pH
7.4) at room temperature for 1 h, and the blots were
probed with rabbit monoclonal antibody to 14-3-3σ, 14-3-
3ε and 14-3-3δ, and mouse monoclonal antibody for β-
actin. The proteins were visualized using an enhanced
chemiluminescence kit (ECL) and Western blotting detec-
tion reagents (GE Healthcare Life Sciences), and exposed
to X-ray film (Fuji, Tokyo, Japan). Each band was quanti-
tatively determined using Image J (http://rsb.info.nih.gov)
software. The densitometry readings of the bands were
normalized to β-actin expression.
Statistical analysis
The data represents the mean±standard deviation (SD)
of three independent experiments. The statistical signifi-
cance between the control and sample groups was cal-
culated by the Student’s t-test. A p value <0.05 was
considered as significant.
Results
Growth inhibition of AGS cells by vitamin C
To evaluate the effects of growth inhibition and survival
of AGS cells, the AGS cells were cultured in the pres-
ence of various concentrations (0-500 μg/mL) of vita-
min C for 24 h. Vitamin C had a strong inhibitory effect
on cell proliferation of AGS cells in a dose-dependent
manner when compared to the control, after 24 h treat-
ment with vitamin C (Figure 1A). Especially, vitamin C
at 300, 400 and 500 μg/mL decreased the cell growth
by approximately 50%, 36% and 27%, respectively.
Therefore, the IC50 (50% inhibitory concentration) of
vitamin C was found to be approximately 300 μg/mL.
Moreover, microscopic observations revealed morphological
Figure 1 Effects of vitamin C on cell viability on AGS adenocarcinoma gastric cancer cell line. (A) The cells were exposed to vitamin C at the
indicated dosages for 24 h and cell viability was determined. Vehicle-treated cells were arbitrarily set as 100% control viability. (B) Morphology of AGS
cells treated with or without vitamin C for 24 h and examined by light microscopy (400). Results are expressed as the mean ± SD of three independent
experiments (*P < 0.05; **P < 0.01, compared to control).
Nagappan et al. BMC Biochemistry 2013, 14:24 Page 4 of 11
http://www.biomedcentral.com/1471-2091/14/24changes in AGS cells, such as cell shrinkage and dens-
ity compared with the control cells (Figure 1B). Further,
2-DE gel analysis was performed to study the protein
expressions in AGS cells due to inhibitory effects of
vitamin C.Proteomic analysis to identify differentially expressed
proteins in vitamin C-treated AGS cells
We performed a proteomic approach to identify proteins
that were differentially expressed in vitamin C treated
(300 μg/mL) AGS cells, 100 μg of total proteins were sepa-
rated by IEF on 18 cm IPG strips in the first dimension
and 12% SDS-PAGE in the second dimension. We ob-
served a total of approximately 500 protein spots in silver
stained gels. Control (only vehicle) and vitamin C treated
gels were analyzed by using Progenesis Samespots software
(Nonlinear Dynamics, Newcastle, UK), and we found 32
statistically significant differentially expressed protein spots
(≥2-fold and p<0.05). These 32 differentially expressed pro-
teins spots were chosen for further analysis by MALDI-
TOF/MS. Finally, 20 differentially expressed proteins were
successfully identified by using the MASCOT search en-
gine and the SwissProt database (Figure 2 and Table 1).Of these 20 proteins, six were up-regulated and fourteen
were down-regulated in vitamin C-treated AGS cells com-
pared with the control. Down-regulated proteins involved
in cell motility included tropomyosin alpha-3 chain
(TPM3) and tropomyosin alpha-4 chain (TPM4), whereas
Xin actin-binding repeat-containing protein 1 (XIRP1) was
up-regulated. In addition, the peroxiredoxin-4 (PRDX4)
and thioredoxin domain-containing protein 5 (TXND5)
were involved in antioxidant and detoxification, which was
up-regulated. While proteins participating in signal
transduction were significantly down-regulated, includ-
ing 14-3-3 protein sigma (SFN), 14-3-3 protein epsilon
(YWHAE) and 14-3-3 protein zeta/delta (YWHAZ),
whereas TNFAIP3-interacting protein 2 (TNIP2) was up-
regulated. Proteins involved in protein metabolism Eukar-
yotic translation initiation factor 3 subunit K (EIF3K),
Proteasome subunit alpha type-5 (PSMA5) and Prote-
asome subunit beta type-6 (PSMB6) were down-regulated.
Further, we showed the enlarged 2-DE images of 6 import-
ant protein spots, one spot (Peroxiredoxin-4) was up-
regulated and the other five (14-3-3σ, 14-3-3ε, 14-3-3δ,
tropomyosin alpha-3 chain and tropomyosin alpha-4
chain) were down-regulated in the vitamin C-treated AGS
cells compared with the control (Figure 3).
Figure 2 Two-dimensional map of proteins from AGS gastric cancer cells treated with vitamin C. Proteins were isolated after exposure of
the cells to A) control (only vehicle) and B) 300 μg/ml of vitamin C for 24 h and separated on IPG-strips with pH 4–7 in the first dimension, and
then on 12% polyacrylamide gel on second dimension. The gels were silver stained.
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immunoblotting
Recent research on cancer targets have focused 14-3-3 pro-
teins that are known to be involved in various biological
processes like signal transduction, cell cycle control, apop-
tosis, cellular metabolism, proliferation, cytoskeletal regula-
tion, transcription, and redox-regulation or stress response.
The AGS cells were treated with vitamin C (0, and 300 μg/
mL) and the expression of 14-3-3σ, 14-3-3ε and 14-3-3δ
were examined by immuno-blotting. Quantification of the
protein bands revealed that the expression of 14-3-3σ, 14-
3-3ε and 14-3-3δ were decreased in the vitamin C-treated
group compared to the vehicle-treated control group
(Figure 4). These data indicated that vitamin C decreased
the expression of 14-3-3 isoforms (14-3-3σ, 14-3-3ε and
14-3-3δ) in AGS cells.
Discussion
Apart from antioxidant activity, vitamin C plays an effect-
ive role of cancer prevention and treatment. The numerous
studies have reported that vitamin C prevents cell prolifer-
ation and metastasis of many human cancer cells [17-19].
But, it’s exact molecular mechanisms still has not been fully
elucidated. In the previous study, we demonstrated that
vitamin C at pharmacological concentration induced apop-
tosis in AGS cells, mainly through the down-regulation of14–3-3σ protein and dephosphorylation Bad proteins via
a mitochondrial dependent pathway [14]. In the present
study, we performed 2-DE analysis coupled with MALDI-
TOF/MS of AGS cells treated with vitamin C at a pharma-
cological concentration (300 μg/mL) and the control (only
vehicle), and 20 differentially expressed proteins were iden-
tified. Proteomic analysis revealed that the apoptosis re-
lated proteins were involved in promoting and regulating
cell death of AGS cells.
Ascorbic acid is an excellent antioxidant and ascorbate
caused toxicity to cancer cells, but had no effect on nor-
mal cells at the same concentration [20]. In the present
study, vitamin C had a strong inhibitory effect on cell pro-
liferation of AGS cells in a dose-dependent manner after
24 h treatment with vitamin C (Figure 1A), and the IC50
of vitamin C was found approximately 300 μg/mL or 1.7
mM/mL. And also, morphological changes were observed
in AGS cells, such as cell shrinkage and density in vitamin
C treated cells compared with the control cells (Figure 1B).
This result revealed that vitamin C inhibited AGS cell
growth at pharmacological concentrations. Further, 2-DE
gel analysis was performed to study the protein expres-
sions in AGS cells due to inhibitory effects of vitamin C.
The silver stained gels of control (only vehicle) and vita-
min C treated gels were analyzed by using Progenesis
Samespots software (Nonlinear Dynamics, Newcastle,




















Up - regulated proteins
2 TNIP2_HUMAN TNFAIP3-interacting
protein 2
Q8NFZ5 49.24/91 6.03/5.83 56 15/7 2.3
3 XIRP1_HUMAN Xin actin-binding
repeat-containing
protein 1
Q702N8 199.64/96 5.78/6.48 59 11/13 2.2
6 TXND5_HUMAN Thioredoxin domain-
containing protein 5
Q8NBS9 48.28/49 5.63/5.38 81 22/10 2.9
7 CE290_HUMAN Centrosomal protein of
290 kDa
O15078 290.89/28 5.75/6.04 69 9/16 8.5
8 PRDX4_HUMAN Peroxiredoxin-4 Q13162 30.75/24 5.86/5.43 68 38/6 3.0
9 CE290_HUMAN Centrosomal protein of
290 kDa
O15078 290.89/23 5.75/5.21 60 8/15 6.4
Down - regulated proteins
1 DPP3_HUMAN Dipeptidyl peptidase 3 Q9NY33 82.88/100 5.02/4.86 110 26/12 4.0
4 DCTN2_HUMAN Dynactin subunit 2 Q13561 44.32/51 5.10/4.94 122 39/13 2.3
5 IF4A1_HUMAN Eukaryotic initiation
factor 4A-I
P60842 46.35/48 5.32/5.31 175 47/17 2.1
10 PSB6_HUMAN Proteasome subunit
beta type-6
PSMB6 25.57/21 4.80/4.64 104 39/10 4.4
11 EIF3K_HUMAN Eukaryotic translation
initiation factor 3
subunit K
Q9UBQ5 25.33/21 4.81/4.46 101 37/8 3.6
12 PSA5_HUMAN Proteasome subunit
alpha type-5
P28066 26.57/24 4.74/4.31 91 41/8 2.0
13 IF6_HUMAN Eukaryotic translation
initiation factor 6
P56537 27.10/23 4.56/4.13 86 50/7 3.8
14 1433Z_HUMAN 14-3-3 protein zeta/
delta
P63104 27.9/25 4.73/4.36 93 40/10 2.6
15 1433S_HUMAN 14-3-3 protein sigma P31947 27.87/25 4.68/4.26 150 58/12 2.2
16 1433E_HUMAN 14-3-3 protein epsilon P62258 29.33/26 4.63/4.27 131 93/12 2.3
17 EF1B_HUMAN Elongation factor 1-beta P24534 24.92/26 4.50/4.12 130 50/11 3.3
18 TPM4_HUMAN Tropomyosin alpha-4
chain
P67936 28.62/27 4.67/4.28 94 25/10 3.1
19 TPM3_HUMAN Tropomyosin alpha-3
chain
P06753 32.86/27 4.68/4.37 95 20/11 2.7
20 PCNA_HUMAN Proliferating cell nuclear
antigen
P12004 29.09/29 4.57/4.28 127 40/10 2.5
1Entry name, protein name and accession number from SWISS-PROT database identified by MALDI-TOF/MS.
2Theoretical molecular weight (kDa) and pI from SWISS-PROT database; the experimental values of pI and MW for every isoelectric spot were calculated using
Progenesis samespots software (Nonlinear Dynamics Ltd., Newcastle, UK).
3Score is −10*log (p), where p is the probability that the observed match is a random event, Protein scores greater than 56 are significant (p<0.05).
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expressed protein spots (≥2-fold and p<0.05). Finally, 20
differentially expressed proteins were successfully identi-
fied by MALDI-TOF/MS analysis using the MASCOT
search engine and the SwissProt database (Figure 2 and
Table 1). Among 20 proteins, six were up-regulated and
fourteen were down-regulated in vitamin C-treated AGS
cells compared with the control. These proteins are mainlyinvolved in cell mobility, antioxidant and detoxification,
signal transduction and protein metabolism.
Vitamin C down-regulated proteins involved in the signal
transduction, 14-3-3 isoforms
Research on cancer targets have determined that 14-3-3
proteins are known to be involved in various biological
processes like signal transduction, cell cycle control,
Figure 3 Enlargements of the 2-DE map of proteins from AGS gastric cancer cells treated with vitamin C, which displays
corresponding sections of gels with protein spots derived from control and vitamin C treated cells. Three independent experiments were
performed and the mean ± SD was plotted (*P < 0.05, **P < 0.01 compared with control).
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regulation, transcription, and redox-regulation or stress
response [21]. Among these differentially expressed pro-
teins, three isoforms of 14-3-3 proteins, 14-3-3σ and 14-3-
3ε and 14-3-3δ were down-regulated (Figure 2). The Bad
protein, a proapoptotic family member, is one of the
targets of 14-3-3 proteins [22]. When Bad disassociated
from 14-3-3, the Bad is found localized to the mitochon-
dria bound to Bcl-2 and Bcl-xL, and induced cell death
[23,24]. In addition, vitamin C induced apoptosis bydown-regulation of 14–3-3σ and dephosphorylation of
Bad via a mitochondrial dependent pathway in AGS cells
[14]. Moreover, the remarkable dissociation of Bad from
14-3-3β is the apoptosis mechanism of vitamin C through
the increasing of ER stress and the translocation of Bad to
mitochondria after dissociation from 14-3-3β in human
colon cancer cell line, HCT-8 [25]. These findings suggest
that Bad dissociated from 14-3-3 is a key mediator in vita-
min C-induced apoptosis through the disruption of mito-
chondrial membrane potential.
Figure 4 Effects of vitamin C on expression of 14-3-3 isoforms in AGS cells. Cells were treated with vitamin C (0 and 300 lg/ml) for 24 h.
The cell lysates were subjected to SDS–PAGE and analyzed by Western blotting. Densitometric analyses of data were expressed as the mean ±
SD of three independent experiments (*P < 0.05, **P < 0.01 compared with control).
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ported in many types of cancer, including breast cancer
[26], and expression is frequently lost in other human epi-
thelial carcinomas [27]. Moreover, other 14-3-3ε, ζ, γ, β, θ
isoforms have also been identified in cancer [28]. After
DNA-damage, 14-3-3σ down-regulated cells fail to maintain
a G2/M arrest and undergo a mitotic catastrophe, which re-
sults in apoptosis [29]. The reduction of 14-3-3ζ expression
induced the G2 arrest, which leads to mitotic catastrophe
and increase radio sensitivity [30]. To verify the expressions
of identified proteins, we performed an immuno-blotting
analysis on 14-3-3σ, 14-3-3ε and 14-3-3δ, which have been
suggested to be involved in various cancers. Quantification
of the protein bands determined that the expression of 14-
3-3σ, 14-3-3ε and 14-3-3δ were decreased in the vitamin
C-treated group compared to the vehicle-treated control
group (Figure 4). These data indicated that vitamin C de-
creased the expression of 14-3-3 isoforms (14-3-3σ, 14-3-
3ε and 14-3-3δ) in AGS cells. These data suggest that
down-regulation of 14-3-3 could be a useful information in
therapeutic targets of human gastric cancers.
Vitamin C down-regulated the cytoskeleton and
associated proteins, tropomyosin alpha-3 chain and
tropomyosin alpha-4 chain proteins
Tropomyosins are actin-binding proteins that can inte-
grate cell mechanics and signaling essential for cellularmigration and invasion. Proteomic studies showed that
the expression of tropomyosin changes, which suggest
an important role for tropomyosin in maintaining cell
shape [31]. In addition, tropomyosins increase filament
stiffness, stabilize actin filaments by protecting them
against the severing action of gelsolin and cofilin [32]. In
our 2 D gel system, the spots corresponding to tropo-
myosin 3 and tropomyosin 4 showed a decreased exp-
ression in the response to vitamin C (Figure 3). These
decreased changes in the tropomyosins expression might
be coincidental with morphologic changes and migratory
characteristics of AGS cells in response to vitamin C.
Vitamin C up-regulated the antioxidant proteins,
peroxiredoxin-4 and thioredoxin domain-containing
protein 5
Generally, antioxidant proteins play a pivotal role in the
antioxidant defense system and protect the cells from oxi-
dative stress. There are six peroxiredoxins found in mam-
malians, and peroxiredoxin 4 (PRDX4) is localized in the
endoplasmic reticulum (ER) [33]. In the present study,
antioxidant and detoxification proteins, like peroxiredoxin-
4 and thioredoxin domain-containing protein 5, were over
expressed in vitamin C treated AGS cells (Figure 3). Since,
vitamin C is an excellent antioxidant that increased anti-
oxidant protein expressions in AGS cells and protects from
oxidative stress. To our knowledge there has not been a
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sion in human gastric cancer adenocarcinoma AGS cells
response to vitamin C. Therefore, a detailed study is neces-
sary regarding the effects of vitamin C on peroxiredoxin-4
protein expressions and the role of peroxiredoxin-4 protein
in tumorigenesis of gastric cancer.
Vitamin C altered the proteins involved in protein
metabolism
Also, we found that EIF3K was down-regulated in vita-
min C-treated AGS cells. A previous study has been
reported that the down-regulation of eIF3k attenuating
apoptosis in simple epithelial cells [34]. Tumor Necrosis
Factor (TNF) Alpha-Induced Protein 3 (also known as
A20-binding inhibitor of NF-kappa-B activation 2) or
TNFAIP3 is a novel tumor suppressor protein and a key
player in the negative feedback regulation of NF-kB
signaling in response to multiple stimuli. TNFAIP3
also regulates TNF-induced apoptosis [35]. Moreover,
TNFAIP3 induces cell growth arrest and apoptosis, ac-
companied by down-regulation of nuclear factor-kappa
B (NF-kB) activation [36,37]. Presently, TNFAIP3 was
up-regulated in vitamin C treated AGS cells. Figure 5
represents the overview of the growth inhibition effectFigure 5 Flow diagram depicts the modulation of proteins expression
down-regulated the 14-3-3 isoforms, cytoskeleton and associated proteins
TXNDC5). The down-regulation of 14-3-3 proteins failed to maintain G2/M
↑ indicates up-regulation).of vitamin C on AGS cells and protein expression pat-
terns. These proteomic results reveal that vitamin C
inhibited cell growth, and apoptosis related proteins
were involved in promoting and regulating cell death in
AGS cells.
Conclusions
In summary, vitamin C showed strong inhibitory effect
on AGS cell growth at pharmacological concentrations
(300 μg/mL), and 20 differentially expressed proteins
were identified in AGS cells after exposure to vitamin C
by using 2-DE and MADLI-TOF analysis. In particular,
proteins involved in signal transduction 14-3-3σ, 14-3-
3ε and 14-3-3δ, and cytoskeletal proteins tropomyosin
alpha-3 chain and tropomyosin alpha-4 chain were
down-regulated; Peroxiredoxin-4 was up-regulated in
vitamin C-treated AGS cells compared with the control.
Further, the expressions of 14-3-3 isoforms (14-3-3σ,
14-3-3ε and 14-3-3δ) were verified with a Western blot
analysis. The findings of this study suggest that vitamin
C could inhibit AGS cell growth, alter the apoptosis re-
lated proteins, and might be helpful to understand the
molecular mechanism of vitamin C ’s anti-tumor effect
in AGS cells.due to inhibitory effect of vitamin C in AGS cells. Vitamin C
(TPM4 and TPM3), and up-regulated antioxidant proteins (PRDX4 and
checkpoint which results in apoptosis. (↓ indicates down-regulation,
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